Recommendations for screening, monitoring, prevention, and prophylaxis of infections in adult and pediatric patients receiving CAR T-cell therapy: a position paper
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Recommendations for screening, monitoring, prevention, and prophylaxis of infections in adult and pediatric patients receiving CAR T-cell therapy: a position paper
Authors
Keywords
-
Journal
INFECTION
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-09-26
DOI
10.1007/s15010-020-01521-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Post-Marketing Use Outcomes of an Anti-CD19 Chimeric Antigen Receptor (CAR) T Cell Therapy, Axicabtagene Ciloleucel (Axi-Cel), for the Treatment of Large B Cell Lymphoma (LBCL) in the United States (US)
- (2020) Marcelo C. Pasquini et al. BLOOD
- Axicabtagene ciloleucel CD19 CAR-T cell therapy results in high rates of systemic and neurologic remissions in ten patients with refractory large B cell lymphoma including two with HIV and viral hepatitis
- (2020) Ahmed Abbasi et al. Journal of Hematology & Oncology
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
- (2020) Chaolin Huang et al. LANCET
- Chimeric Antigen Receptor T Cell Therapy During the COVID-19 Pandemic
- (2020) Veronika Bachanova et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Addressing the Impact of the Coronavirus Disease 2019 (COVID-19) Pandemic on Hematopoietic Cell Transplantation: Learning Networks as a Means for Sharing Best Practices
- (2020) Monica Ardura et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Tocilizumab not associated with increased infection risk after CAR T - Implications for COVID-19?
- (2020) Matthew J Frigault et al. BLOOD
- COVID-19 outcomes in patients with hematologic disease
- (2020) Florent Malard et al. BONE MARROW TRANSPLANTATION
- The challenge of COVID-19 and hematopoietic cell transplantation; EBMT recommendations for management of hematopoietic cell transplant recipients, their donors, and patients undergoing CAR T-cell therapy
- (2020) Per Ljungman et al. BONE MARROW TRANSPLANTATION
- Survival study of hospitalised patients with concurrent COVID‐19 and haematological malignancies
- (2020) Fernando Martín‐Moro et al. BRITISH JOURNAL OF HAEMATOLOGY
- Immune reconstitution and associated infections following axicabtagene ciloleucel in relapsed or refractory large B-cell lymphoma
- (2020) Jennifer M. Logue et al. HAEMATOLOGICA
- Standard-of-Care Axicabtagene Ciloleucel for Relapsed or Refractory Large B-Cell Lymphoma: Results From the US Lymphoma CAR T Consortium
- (2020) Loretta J. Nastoupil et al. JOURNAL OF CLINICAL ONCOLOGY
- COVID-19 illness in native and immunosuppressed states: A clinical–therapeutic staging proposal
- (2020) Hasan K. Siddiqi et al. JOURNAL OF HEART AND LUNG TRANSPLANTATION
- COVID-19 in persons with haematological cancers
- (2020) Wenjuan He et al. LEUKEMIA
- Infectious Complications Following CD19 Chimeric Antigen Receptor T-cell Therapy for Children, Adolescents, and Young Adults
- (2020) Surabhi B Vora et al. Open Forum Infectious Diseases
- How we prevent infections in patients receiving CD19-targeted chimeric antigen receptor T-cells for B-cell malignancies
- (2020) Joshua A. Hill et al. BLOOD
- Infection during the first year in patients treated with CD19 CAR T cells for diffuse large B cell lymphoma
- (2020) Kitsada Wudhikarn et al. Blood Cancer Journal
- Clinical efficacy of anakinra to mitigate CAR T-cell therapy–associated toxicity in large B-cell lymphoma
- (2020) Paolo Strati et al. Blood Advances
- Safety of CAR T-Cell Therapy in Patients with B-Cell Lymphoma and Chronic Hepatitis B or C Virus Infection
- (2019) Paolo Strati et al. BLOOD
- Clinical utilization of Chimeric Antigen Receptor T-cells (CAR-T) in B-cell acute lymphoblastic leukemia (ALL)–an expert opinion from the European Society for Blood and Marrow Transplantation (EBMT) and the American Society for Blood and Marrow Transplantation (ASBMT)
- (2019) Ankit J. Kansagra et al. BONE MARROW TRANSPLANTATION
- Guidelines for the management of cytomegalovirus infection in patients with haematological malignancies and after stem cell transplantation from the 2017 European Conference on Infections in Leukaemia (ECIL 7)
- (2019) Per Ljungman et al. LANCET INFECTIOUS DISEASES
- Late Events after Treatment with CD19-Targeted Chimeric Antigen Receptor Modified T Cells
- (2019) Ana Cordeiro et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- CAR-T – and a side order of IgG, to go? – Immunoglobulin replacement in patients receiving CAR-T cell therapy
- (2019) Joshua A. Hill et al. BLOOD REVIEWS
- Successful anti‐CD19 CAR T‐cell therapy in HIV‐infected patients with refractory high‐grade B‐cell lymphoma
- (2019) Jeremy S. Abramson et al. CANCER
- An international survey on the management of patients receiving CAR T-cell therapy for haematological malignancies on behalf of the Chronic Malignancies Working Party of EBMT
- (2019) P.J. Hayden et al. Current Research in Translational Medicine
- Invasive Mold Infections After Chimeric Antigen Receptor–Modified T-cell Therapy: A Case Series, Review of the Literature, and Implications for Prophylaxis
- (2019) Ghady Haidar et al. CLINICAL INFECTIOUS DISEASES
- Management of adults and children undergoing CAR t-cell therapy: best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE)
- (2019) Ibrahim Yakoub-Agha et al. HAEMATOLOGICA
- Inflammatory signatures for quick diagnosis of life-threatening infection during the CAR T-cell therapy
- (2019) Hui Luo et al. Journal for ImmunoTherapy of Cancer
- Severe early hepatitis B reactivation in a patient receiving anti-CD19 and anti-CD22 CAR T cells for the treatment of diffuse large B-cell lymphoma
- (2019) Jia Wei et al. Journal for ImmunoTherapy of Cancer
- Cytokine Release Syndrome Grade as a Predictive Marker for Infections in Patients With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia Treated With Chimeric Antigen Receptor T Cells
- (2018) Jae H Park et al. CLINICAL INFECTIOUS DISEASES
- ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Soluble immune effector molecules [II]: agents targeting interleukins, immunoglobulins and complement factors)
- (2018) K.L. Winthrop et al. CLINICAL MICROBIOLOGY AND INFECTION
- EASL Recommendations on Treatment of Hepatitis C 2018
- (2018) Jean-Michel Pawlotsky et al. JOURNAL OF HEPATOLOGY
- Vacunas para pacientes en tratamiento con fármacos inmunodepresores, inmunomoduladores o biológicos
- (2018) Paula Peremiquel-Trillas et al. MEDICINA CLINICA
- Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
- (2018) Shannon L. Maude et al. NEW ENGLAND JOURNAL OF MEDICINE
- Management of adenovirus infection in patients after haematopoietic stem cell transplantation: State-of-the-art and real-life current approach
- (2018) Prashant Hiwarkar et al. REVIEWS IN MEDICAL VIROLOGY
- Community-Acquired Respiratory Paramyxovirus Infection After Allogeneic Hematopoietic Cell Transplantation: A Single-Center Experience
- (2018) Yasmin Spahr et al. Open Forum Infectious Diseases
- ASBMT Pharmacy Special Interest Group Survey on CAR T Cell Therapy Administrative, Logistical and Toxicity Management Practices in the United States
- (2018) Zahra Mahmoudjafari et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Clinical effectiveness of influenza vaccination after allogeneic hematopoietic stem cell transplantation: A cross-sectional prospective observational study
- (2018) José Luis Piñana et al. CLINICAL INFECTIOUS DISEASES
- Safety of influenza vaccination in patients undergoing immunotherapy treatment for advanced cancer.
- (2018) Curtis Robert Chong et al. JOURNAL OF CLINICAL ONCOLOGY
- Management guidelines for paediatric patients receiving chimeric antigen receptor T cell therapy
- (2018) Kris M. Mahadeo et al. Nature Reviews Clinical Oncology
- Hepatitis B virus and hepatitis C virus infection in immunocompromised patients
- (2018) Jessica P. Hwang et al. CURRENT OPINION IN INFECTIOUS DISEASES
- Long-term safety and activity of axicabtagene ciloleucel in refractory large B-cell lymphoma (ZUMA-1): a single-arm, multicentre, phase 1–2 trial
- (2018) Frederick L Locke et al. LANCET ONCOLOGY
- Tisagenlecleucel in Adult Relapsed or Refractory Diffuse Large B-Cell Lymphoma
- (2018) Stephen J. Schuster et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial of Oral Brincidofovir for Cytomegalovirus Prophylaxis in Allogeneic Hematopoietic Cell Transplantation
- (2018) Francisco M. Marty et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Hepatitis B reactivation in occult viral carriers undergoing hematopoietic stem cell transplantation: A prospective study
- (2017) Wai-Kay Seto et al. HEPATOLOGY
- Update on the use of immunoglobulin in human disease: A review of evidence
- (2017) Elena E. Perez et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective cohort study
- (2017) Belén Gutiérrez-Gutiérrez et al. LANCET INFECTIOUS DISEASES
- Chimeric Antigen Receptor T Cells in Refractory B-Cell Lymphomas
- (2017) Stephen J. Schuster et al. NEW ENGLAND JOURNAL OF MEDICINE
- Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma
- (2017) Sattva S. Neelapu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Hypogammaglobulinemia due to CAR T-cell therapy
- (2017) Andrew Doan et al. PEDIATRIC BLOOD & CANCER
- Respiratory virus infection after allogeneic hematopoietic stem cell transplant in a tropical center: Predictive value of the immunodeficiency scoring index
- (2017) Lin Wang et al. Transplant Infectious Disease
- Imported Disease Screening Prior to Chemotherapy and Bone Marrow Transplantation for Oncohematological Malignancies
- (2016) Adrián Sánchez-Montalvá et al. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
- Outcomes of Influenza Infections in Hematopoietic Cell Transplant Recipients: Application of an Immunodeficiency Scoring Index
- (2016) Joumana Kmeid et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- How I vaccinate blood and marrow transplant recipients
- (2016) P. A. Carpenter et al. BLOOD
- Persistence of long-lived plasma cells and humoral immunity in individuals responding to CD19-directed CAR T-cell therapy
- (2016) V. G. Bhoj et al. BLOOD
- Management of viral hepatitis in patients with haematological malignancy and in patients undergoing haemopoietic stem cell transplantation: recommendations of the 5th European Conference on Infections in Leukaemia (ECIL-5)
- (2016) Vincent Mallet et al. LANCET INFECTIOUS DISEASES
- American Gastroenterological Association Institute Guideline on the Prevention and Treatment of Hepatitis B Virus Reactivation During Immunosuppressive Drug Therapy
- (2015) K. Rajender Reddy et al. GASTROENTEROLOGY
- Reactivation of hepatitis B virus (HBV) infection in adult T-cell leukemia–lymphoma patients with resolved HBV infection following systemic chemotherapy
- (2015) Haruhito Totani et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Risk of Severe Acute Exacerbation of Chronic HBV Infection Cancer Patients Who Underwent Chemotherapy and Did Not Receive Anti-Viral Prophylaxis
- (2015) Chih-An Shih et al. PLoS One
- Immunodeficiency scoring index to predict poor outcomes in hematopoietic cell transplant recipients with RSV infections
- (2014) D. P. Shah et al. BLOOD
- Executive Summary: 2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host
- (2014) Lorry G. Rubin et al. CLINICAL INFECTIOUS DISEASES
- Serum Galactomannan-Based Early Detection of Invasive Aspergillosis in Hematology Patients Receiving Effective Antimold Prophylaxis
- (2014) R. F. Duarte et al. CLINICAL INFECTIOUS DISEASES
- Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia
- (2014) Shannon L. Maude et al. NEW ENGLAND JOURNAL OF MEDICINE
- Comparison of American and European practices in the management of patients with primary immunodeficiencies
- (2012) H. S. Hernandez-Trujillo et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Integrated safety in tocilizumab clinical trials
- (2011) Michael H Schiff et al. ARTHRITIS RESEARCH & THERAPY
- Galactomannan Detection and Diagnosis of Invasive Aspergillosis
- (2010) J. Peter Donnelly et al. CLINICAL INFECTIOUS DISEASES
- Outcome of influenza infections in outpatients after allogeneic hematopoietic stem cell transplantation
- (2009) N. Khanna et al. Transplant Infectious Disease
- Human metapneumovirus infection in hematopoietic stem cell transplant recipients
- (2009) M.C. Debur et al. Transplant Infectious Disease
- Risk of serious infections during rituximab, abatacept and anakinra treatments for rheumatoid arthritis: meta-analyses of randomised placebo-controlled trials
- (2008) C Salliot et al. ANNALS OF THE RHEUMATIC DISEASES
- Biologic IgG level in primary immunodeficiency disease: The IgG level that protects against recurrent infection
- (2008) Vincent R. Bonagura et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now